Dr. Andrew Marc Schneider, MD

Dr. Schneider practices at South Florida Oncology and Hematology Consultants in Tamarac, Florida.

Dr. Schneider's NPI, 1548276140, was assigned on August 1, 2006. Dr. Schneider graduated from Jacobs School of Medicine and Biomedical Sciences in 1984. Dr. Schneider holds Florida license ME0055189.

Dr. Schneider's primary practice is South Florida Oncology and Hematology Consultants, at 7351 W Oakland Park Blvd, Tamarac, FL 33319 in Broward County. The practice phone is (954) 749-6951.

Dr. Schneider's primary practice is South Florida Oncology and Hematology Consultants in Tamarac, Florida. Dr. Schneider is also affiliated with HCA Florida Woodmont Hospital. The medical group on file is South Florida Oncology and Hematology Consultants. Dmand AI also links Dr. Schneider to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schneider practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Schneider's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Schneider is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dmand AI has Dr. Schneider's licenses on file in 9 states: Florida, New York, Washington, Kentucky, Oregon, Hawaii, Pennsylvania, Texas and Nebraska.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, multiple myeloma and prostate cancer among the conditions Dr. Schneider treats.

CMS data shows 21,118 Medicare services from Dr. Schneider across 13 procedure codes in 2024, for 136 Medicare patients. Medicare paid $57,922 for them.

CMS counts 136 Medicare patients who saw Dr. Schneider in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schneider's median patient age at 76, with 59% women.

In 2024, Dr. Schneider wrote 866 Medicare Part D claims for 224 patients. 54% of them were for generic drugs. CMS names the drug for 612 of them, across 26 drugs with 11 or more claims each, at $2,636,368 in total drug cost. In 2023, CMS named 537 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Schneider for performance year 2024, reported as part of a group. Dr. Schneider accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 96 general payments to Dr. Schneider from 26 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 72% of the total. Janssen Pharmaceuticals, Inc paid the most, $519.

Dmand AI lists 1 award for Dr. Schneider, most recently Top Doctors:South Florida in 2012.

Dr. Schneider graduated from Jacobs School of Medicine and Biomedical Sciences in 1984.

Dr. Schneider is in network with 14 carriers, including United Healthcare, Elevance and Cigna. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.